Skip to content

Clinical trials

Phase 3 Nephritis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Nephritis Phase: Phase 3 Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20111
20121
20152
20161
20221
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated4
Recruiting2
Active, not recruiting1
Completed1
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Anthera Pharmaceuticals2
Novartis Pharmaceuticals2
Astellas Pharma Inc1
Biohaven Therapeutics Ltd.1
Cerium Pharmaceuticals, Inc.1
Human Genome Sciences Inc., a GSK Company1
Imperial College London1
La Jolla Pharmaceutical Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Nephritis10
Lupus Erythematosus, Systemic6
Lupus Nephritis5
Autoimmune Diseases4
Kidney Diseases4
Glomerulonephritis3
Glomerulonephritis, IGA2
Renal Insufficiency, Chronic2
Urologic Diseases2
Female Urogenital Diseases1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.